Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionk0upt8dv72jh85jueb7fiuo2ttvaes5m): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Research data management (RDM) is central to the implementation of the FAIR (Findable Accessible, Interoperable, Reusable) and Open Science principles. Recognising the importance of RDM, ELIXIR Platforms and Nodes have invested in RDM and launched various projects and initiatives to ensure good data management practices for scientific excellence. These projects have resulted in a rich set of tools and resources highly valuable for FAIR data management. However, these resources remain scattered across projects and ELIXIR structures, making their dissemination and application challenging. Therefore, it becomes imminent to coordinate these efforts for sustainable and harmonised RDM practices with dedicated forums for RDM professionals to exchange knowledge and share resources. The proposed ELIXIR RDM Community will bring together RDM experts to develop ELIXIR's vision and coordinate its activities, taking advantage of the available assets. It aims to coordinate RDM best practices and illustrate how to use the existing ELIXIR RDM services. The Community will be built around three integral pillars, namely, a network of RDM professionals, RDM knowledge management and RDM training expertise and resources. It will also engage with external stakeholders to leverage benefits and provide a forum to RDM professionals for regular knowledge exchange, capacity building and development of harmonised RDM practices, keeping in line with the overall scope of the RDM Community. In the short term, the Community aims to build upon the existing resources and ensure that the content of these remain up to date and fit for purpose. In the long run, the Community will aim to strengthen the skills and knowledge of its RDM professionals to support the emerging needs of the scientific community. The Community will also devise an effective strategy to engage with other ELIXIR structures and international stakeholders to influence and align with developments and solutions in the RDM field.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11474151 | PMC |
http://dx.doi.org/10.12688/f1000research.146301.2 | DOI Listing |
R Soc Open Sci
December 2024
Institute of Psychology, ELTE, Eotvos Lorand University, Budapest, Hungary.
The retraction of an article is probably the most severe outcome of a scientific project. While great emphasis has been placed on articles retracted due to scientific misconduct, studies show many retractions are due to honest errors. Unfortunately, in most cases, retraction notices do not provide sufficient information to determine the specific types and causes of these errors.
View Article and Find Full Text PDFDig Liver Dis
December 2024
Gastroenterology Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.
Background And Aims: The quality of a colonoscopy is heavily reliant on the effectiveness of bowel cleansing. Various cleansing solutions are currently available, but their comparative efficacy remains uncertain. This systematic review and network meta-analysis aims to compare the performance of different bowel preparations for colonoscopy.
View Article and Find Full Text PDFAcad Radiol
December 2024
Department of Radiology, Indiana University, 702 North Barnhill Drive, Room 1053, Indianapolis, Indiana 46202 (R.D.M., S.D.G., K.M.F., A.A., R.B.G.). Electronic address:
Eur J Prev Cardiol
December 2024
Arrhythmology Department, Teknon Medical Centre, Barcelona, Spain.
Nature
December 2024
CatalYm, Munich, Germany.
Cancer immunotherapies with antibodies blocking immune checkpoint molecules are clinically active across multiple cancer entities and have markedly improved cancer treatment. Yet, response rates are still limited, and tumour progression commonly occurs. Soluble and cell-bound factors in the tumour microenvironment negatively affect cancer immunity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!